| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 127, 2090-2098, Copyright © 1990 by Endocrine Society
ARTICLES |
MT Vuhai-Luuthi, A Jolivet, B Jallal, R Salesse, JM Bidart, A Houllier, A Guiochon-Mantel, J Garnier and E Milgrom
Institut National de la Sante et de la Recherche Medicale, Unite 135, Hormones et Reproduction, Hopital de Bicetre, Le Kremlin-Bicetre, France.
Human CG (hCG)-receptor complexes were solubilized from porcine testicular membranes. They were chromatographed on an immunomatrix of Affi-Gel 10-D1E8 anti beta-hCG monoclonal antibody (this antibody has been shown not to interfere with hCG binding to receptor). Elution was performed at alkaline pH, a condition in which hCG-receptor complexes are relatively stable. Immunization of a mouse with these partially (approximately 15%) purified hormone-receptor complexes allowed the preparation of 20 different hybridomas, each secreting antireceptor antibodies. The latter were used for receptor characterization. Immunoblot of testicular membrane extracts or of purified receptor preparations showed the presence of a major band at approximately 85,000 mol wt and minor bands at approximately 68,000 mol wt and approximately 48-45,000 mol wt. The width of all these bands suggested some microheterogeneity possibly due to glycosylation. The same approximately 85,000 mol wt receptor was seen in ovarian membranes, but no detectable antigen was observed in liver, muscle, and kidney membranes. An immunoaffinity method (using antibody LHR 38) was devised to purify the receptor in a single step. This demonstrated that the purified receptor preparation did not contain any protein component other than those detected by immunoblot. Comparison of receptors purified by immunoaffinity chromatography using either antireceptor or antihormone monoclonal antibodies showed in both cases the presence of the 85,000 mol wt and 48-45,000 mol wt species, but the absence, in the latter case, of the 68,000 mol wt species. This suggests that the 68,000 mol wt receptor cannot bind hormone and does not form oligomers with other receptor species.
This article has been cited by other articles:
![]() |
M. Ascoli Learning New Tricks from an Old Dog: The Processing of the Intracellular Precursor of the Luteinizing Hormone Receptor (LHR) into the Mature Cell-Surface LHR Is a Regulated Process Endocrinology, August 1, 2005; 146(8): 3221 - 3223. [Full Text] [PDF] |
||||
![]() |
B. Karges, S. Gidenne, C. Aumas, F. Haddad, P. A. Kelly, E. Milgrom, and N. de Roux Zero-Length Cross-Linking Reveals that Tight Interactions between the Extracellular and Transmembrane Domains of the Luteinizing Hormone Receptor Persist during Receptor Activation Mol. Endocrinol., August 1, 2005; 19(8): 2086 - 2098. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ghinea, C. Baratti-Elbaz, A. De Jesus-Lucas, and E. Milgrom TSH Receptor Interaction with the Extracellular Matrix: Role on Constitutive Activity and Sensitivity to Hormonal Stimulation Mol. Endocrinol., May 1, 2002; 16(5): 912 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Meduri, N. Charnaux, M.-A. Driancourt, L. Combettes, P. Granet, B. Vannier, H. Loosfelt, and E. Milgrom Follicle-Stimulating Hormone Receptors in Oocytes? J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2266 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baratti-Elbaz, N. Ghinea, O. Lahuna, H. Loosfelt, C. Pichon, and E. Milgrom Internalization and Recycling Pathways of the Thyrotropin Receptor Mol. Endocrinol., October 1, 1999; 13(10): 1751 - 1765. [Abstract] [Full Text] |
||||
![]() |
G. Goudet, F. Belin, J. Bézard, and N. Gérard Intrafollicular Content of Luteinizing Hormone Receptor, {alpha}-Inhibin, and Aromatase in Relation to Follicular Growth, Estrous Cycle Stage, and Oocyte Competence for In Vitro Maturation in the Mare Biol Reprod, May 1, 1999; 60(5): 1120 - 1127. [Abstract] [Full Text] |
||||
![]() |
R. M. Rajagopalan-Gupta, M. L. G. Lamm, S. Mukherjee, M. M. Rasenick, and M. Hunzicker-Dunn Luteinizing Hormone/Choriogonadotropin Receptor-Mediated Activation of Heterotrimeric Guanine Nucleotide Binding Proteins in Ovarian Follicular Membranes Endocrinology, November 1, 1998; 139(11): 4547 - 4555. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Paukku, P. Ahtiainen, A.-M. Haavisto, and I. T. Huhtaniemi Persistence of Biological Activity of Biotinylated Human Chorionic Gonadotropin and Its Use for Visualization of Rat Luteinizing Hormone Receptors in Tissue Sections J. Histochem. Cytochem., September 1, 1998; 46(9): 993 - 998. [Abstract] [Full Text] |
||||
![]() |
R. M. Rajagopalan-Gupta, M. M. Rasenick, and M. Hunzicker-Dunn Luteinizing Hormone/Choriogonadotropin-Dependent, Cholera Toxin-Catalyzed Adenosine 5'-Diphosphate (ADP)-Ribosylation of the Long and Short Forms of Gs{alpha} and Pertussis Toxin-Catalyzed ADP-Ribosylation of Gi{alpha} Mol. Endocrinol., May 1, 1997; 11(5): 538 - 549. [Abstract] [Full Text] |
||||
![]() |
I. Beau, M. Misrahi, B. Gross, B. Vannier, H. Loosfelt, M. T. V. Hai, C. Pichon, and E. Milgrom Basolateral Localization and Transcytosis of Gonadotropin and Thyrotropin Receptors Expressed in Madin-Darby Canine Kidney Cells J. Biol. Chem., February 21, 1997; 272(8): 5241 - 5248. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Couet, S. Sar, A. Jolivet, M.-T. V. Hai, E. Milgrom, and M. Misrahi Shedding of Human Thyrotropin Receptor Ectodomain J. Biol. Chem., February 23, 1996; 271(8): 4545 - 4552. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bernardini, I. Moretti-Rojas, M. Brush, F. J. Rojas, and J. P. Balmaceda Status of hCG/LH Receptor and G Proteins in Human Endometrium During Artificial Cycles of Hormone Replacement Therapy Reproductive Sciences, July 1, 1995; 2(4): 630 - 635. [Abstract] [PDF] |
||||
![]() |
J.-J. Remy, C. Nespoulous, J. Grosclaude, D. Grebert, L. Couture, E. Pajot, and R. Salesse Purification and Structural Analysis of a Soluble Human Chorionogonadotropin Hormone-Receptor Complex J. Biol. Chem., January 12, 2001; 276(3): 1681 - 1687. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |